glycidyl nitrate has been researched along with Infectious Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chhibber, S; Gondil, VS; Harjai, K | 1 |
| Chen, GY; Trindade, BC | 1 |
| Dagil, YA; Pashenkov, MV; Pinegin, BV | 1 |
| de Kleijn, DP; Oude Nijhuis, MM; Pasterkamp, G; Quax, PH; van Keulen, JK | 1 |
4 review(s) available for glycidyl nitrate and Infectious Diseases
| Article | Year |
|---|---|
Endolysins as emerging alternative therapeutic agents to counter drug-resistant infections.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteriophages; Catalytic Domain; Cell Wall; Communicable Diseases; Drug Resistance, Multiple, Bacterial; Endopeptidases; Host Specificity; Humans; Peptidoglycan | 2020 |
NOD1 and NOD2 in inflammatory and infectious diseases.
Topics: Communicable Diseases; Humans; Immunity, Innate; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Peptidoglycan | 2020 |
NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases.
Topics: Animals; Communicable Diseases; Humans; Immunity, Innate; Molecular Targeted Therapy; Nod1 Signaling Adaptor Protein; Nod2 Signaling Adaptor Protein; Peptidoglycan; Receptor Cross-Talk; Receptors, Pattern Recognition | 2018 |
Activation of the innate immune system in atherosclerotic disease.
Topics: Animals; Atherosclerosis; Communicable Diseases; Humans; Immunity, Innate; Immunotherapy; Inflammation; Ligands; Lipopolysaccharides; Lipoproteins; Peptidoglycan; Signal Transduction; Toll-Like Receptors; Vaccines | 2007 |